Clinical Features of Primary Cicatricial Alopecia in Chinese Patients

    Shiling Qi, Ying Zhang, Xiaoting Zhang, Shuifeng Li, Hui Cao, Xingqi Zhang
    Image of study
    TLDR Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.
    In the retrospective study from 2014, researchers examined 59 Chinese patients with primary cicatricial alopecia (PCA) and found a neutrophilic to lymphocytic cicatricial alopecias ratio of approximately 1.3:1. Folliculitis decalvans was the most common disorder, accounting for 40.7% of cases, and lichen planopilaris was less common in this cohort compared to Western populations, at only 3.4%. Dermoscopy was a valuable diagnostic tool, showing absent follicular openings in most cases. Treatment improved hair loss areas, particularly in patients with discoid lupus erythematosus, folliculitis decalvans, and dissecting cellulitis, but relapse occurred in 13.6% of patients after stopping therapy. Factors such as long disease duration, large areas of hair loss, and shorter treatment courses contributed to relapses. The study emphasized the importance of dermoscopy in diagnosing PCA and assessing disease activity, and noted that better outcomes were associated with certain conditions, although relapses were common due to various factors including non-compliance and financial constraints.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 289 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 8 months ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

      community We need to keep these snake oil companies accountable.

      in Treatment  119 upvotes 6 months ago
      Biotin is being misleadingly marketed as a primary treatment for androgenic alopecia, overshadowing more effective treatments like finasteride and minoxidil. There is a call for increased awareness and accountability to prevent misinformation.

    Related Research

    6 / 6 results